Oral Curcumin for Tendon Health: An Appraisal on Carrier Systems, Bioenhancers, and Synergistic Formulations

Native curcumin's clinical utility is severely limited by poor solubility and rapid metabolism. While preclinical models demonstrate potent effects on tendon repair, achieving therapeutic concentrations in humans requires advanced formulation strategies. This review aims to reiterate the pharmacokinetic (PK) limitations inherent to native curcumin and critically appraise current oral formulation strategies designed to enhance its bioavailability. It further delineates the role of other adjunct compounds that may or may not be incorporated into curcumin formulations for tendon repair. By synthesizing available human pharmacokinetic data, this review evaluates the clinical potential of curcumin formulations in the management of tendinopathy. Human pharmacokinetic data on current curcumin delivery systems are synthesized. The primary functions of common formulation adjuncts such as piperine, EGCG, bromelain, and boswellia are evaluated for their benefits as bioenhancers or independent therapeutics for tendon health. Clinical outcomes from studies utilizing these combined formulations in tendinopathies are also reviewed. Analysis of dose-normalized PK data confirms that modern formulations significantly improve relative bioavailability compared to native curcumin. However, current evidence suggests that formulation adjuncts contribute primarily through independent biological pathways rather than direct PK bio-enhancement. Clinical evidence suggests these 'multimodal' formulations are associated with accelerated pain reduction, improved functional scores, and reduced non-steroidal antiinflammatory drugs consumption. Tendinopathy management is increasingly moving toward high-efficiency curcumin delivery paired with synergistic co-factors. While enhanced oral formulations show significant clinical association with improved recovery, future research should bridge the gap between plasma levels and direct intratendinous penetration.

Authors

Institutions

Publication Details

Journal
Journal of Dietary Supplements
Published
2026-04-24
DOI
https://doi.org/10.1080/19390211.2026.2662847
Primary Topic
Tendon Structure and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oral Curcumin for Tendon Health: An Appraisal on Carrier Systems, Bioenhancers, and Synergistic Formulations

M. S. Zulfarina, H. N. Siti, M. A. Sharifudin, M. L. Nordin et al.
Journal of Dietary Supplements
Tendon Structure and Treatment
article

Oral Curcumin for Tendon Health: An Appraisal on Carrier Systems, Bioenhancers, and Synergistic Formulations

M. S. Zulfarina, H. N. Siti, M. A. Sharifudin, M. L. Nordin, M. N. A. Taib, P. L. Lua
article en

Abstract

Native curcumin's clinical utility is severely limited by poor solubility and rapid metabolism. While preclinical models demonstrate potent effects on tendon repair, achieving therapeutic concentrations in humans requires advanced formulation strategies. This review aims to reiterate the pharmacokinetic (PK) limitations inherent to native curcumin and critically appraise current oral formulation strategies designed to enhance its bioavailability. It further delineates the role of other adjunct compounds that may or may not be incorporated into curcumin formulations for tendon repair. By synthesizing available human pharmacokinetic data, this review evaluates the clinical potential of curcumin formulations in the management of tendinopathy. Human pharmacokinetic data on current curcumin delivery systems are synthesized. The primary functions of common formulation adjuncts such as piperine, EGCG, bromelain, and boswellia are evaluated for their benefits as bioenhancers or independent therapeutics for tendon health. Clinical outcomes from studies utilizing these combined formulations in tendinopathies are also reviewed. Analysis of dose-normalized PK data confirms that modern formulations significantly improve relative bioavailability compared to native curcumin. However, current evidence suggests that formulation adjuncts contribute primarily through independent biological pathways rather than direct PK bio-enhancement. Clinical evidence suggests these 'multimodal' formulations are associated with accelerated pain reduction, improved functional scores, and reduced non-steroidal antiinflammatory drugs consumption. Tendinopathy management is increasingly moving toward high-efficiency curcumin delivery paired with synergistic co-factors. While enhanced oral formulations show significant clinical association with improved recovery, future research should bridge the gap between plasma levels and direct intratendinous penetration.

Journal of Dietary Supplements
University of Malaya (MY), Sultan Zainal Abidin University (MY)
No poverty
Openalex Percentile: Top 5%
Tendon Structure and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.